Predicting persistent taxane-induced peripheral neuropathy
Researchers have developed a prediction model to ascertain breast cancer survivors’ risk of persistent taxane-induced peripheral neuropathy.
List view / Grid view
Researchers have developed a prediction model to ascertain breast cancer survivors’ risk of persistent taxane-induced peripheral neuropathy.
Researchers have created a new T cell atlas which could aid the development of novel drug therapies for immune-mediated diseases.
Researchers show that proteins released from the brain during migraine with aura are transported by CSF to pain-signalling nerves.
Researchers have discovered that pancreatic cancer’s resistance to chemotherapy is related to the physical stiffness of the extracellular matrix.
PVP-037, identified through a small molecule screen, induces a more durable and broader immune response to vaccines.
Researchers have obtained images with a previously unseen level of detail, demonstrating how RNA polymerase opens the transcription bubble.
Protein biomarkers in spinal fluid linked to PSP could enable earlier diagnosis and treatment for this neurological disorder.
A new assay has been developed which enables the detailing of intact proviral genomes of under-studied HIV strains.
Researchers found that tumour beta cells lose their repression marks and express elevated levels of oncogenes.
Molecular, cellular and metabolic analyses of liver biopsies identified markers that may predict subsequent metastasis of pancreatic cancer.
A new neural network computational model has been developed, which more closely reflects the abilities of real neurons and could advance AI progress.
The tool identified patients with high-risk disease, which normally goes unrecognised by traditional diagnostics.
The hiPSC-derived skeletal muscle model is the first to uncover the biological mechanisms underlying loss of mobility.
The inhibitor, HVH-2930, effectively induced apoptosis in breast cancer cells without initiating the heat shock response.
Researchers have designed synthetic, soluble versions of cell membrane proteins, which will enable faster and easier screening for new drugs.